These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31831191)

  • 1. CD40 Ligand Deficiency.
    Leite LFB; Máximo TA; Mosca T; Forte WCN
    Allergol Immunopathol (Madr); 2020; 48(4):409-413. PubMed ID: 31831191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives.
    França TT; Barreiros LA; Al-Ramadi BK; Ochs HD; Cabral-Marques O; Condino-Neto A
    Expert Rev Clin Immunol; 2019 May; 15(5):529-540. PubMed ID: 30681380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience.
    Allewelt H; Martin PL; Szabolcs P; Chao N; Buckley R; Parikh S
    Pediatr Blood Cancer; 2015 Dec; 62(12):2216-22. PubMed ID: 26291959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARDS as presenting symptom in an infant with CD40L deficiency (Hyper-IgM syndrome Type 1).
    Fremerey C; Wiebe B; Feyen O; Lenski C; Pohlmann U; Ehlen M; Schofer O; Meindl A; Niehues T; Bartmann P
    Klin Padiatr; 2009 Sep; 221(5):302-4. PubMed ID: 19707993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 ligand deficiency: neurologic sequelae with radiographic correlation.
    Bishu S; Madhavan D; Perez P; Civitello L; Liu S; Fessler M; Holland SM; Jain A; Pao M
    Pediatr Neurol; 2009 Dec; 41(6):419-27. PubMed ID: 19931163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin class switch recombination deficiency type 1 or CD40 ligand deficiency: from bedside to bench and back again.
    Hirbod-Mobarakeh A; Aghamohammadi A; Rezaei N
    Expert Rev Clin Immunol; 2014 Jan; 10(1):91-105. PubMed ID: 24308834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked Hyper IgM Syndrome Presenting as Pulmonary Alveolar Proteinosis.
    Gallagher J; Adams J; Hintermeyer M; Torgerson TR; Lopez-Guisa J; Ochs HD; Szabo S; Salib M; Verbsky J; Routes J
    J Clin Immunol; 2016 Aug; 36(6):564-70. PubMed ID: 27324886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-γ.
    Cabral-Marques O; França TT; Al-Sbiei A; Schimke LF; Khan TA; Feriotti C; da Costa TA; Junior OR; Weber CW; Ferreira JF; Tavares FS; Valente C; Di Gesu RSW; Iqbal A; Riemekasten G; Amarante-Mendes GP; Marzagão Barbuto JA; Costa-Carvalho BT; Pereira PVS; Fernandez-Cabezudo MJ; Calich VLG; Notarangelo LD; Torgerson TR; Al-Ramadi BK; Ochs HD; Condino-Neto A
    J Allergy Clin Immunol; 2018 Nov; 142(5):1571-1588.e9. PubMed ID: 29518426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with abnormal IgM levels: assessment, clinical interpretation, and treatment.
    Ochs HD
    Ann Allergy Asthma Immunol; 2008 May; 100(5):509-11. PubMed ID: 18517086
    [No Abstract]   [Full Text] [Related]  

  • 10. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients.
    Tsai HY; Yu HH; Chien YH; Chu KH; Lau YL; Lee JH; Wang LC; Chiang BL; Yang YH
    J Microbiol Immunol Infect; 2015 Feb; 48(1):113-8. PubMed ID: 23010537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel
    Li L; Ji J; Han M; Xu Y; Zhang X; Liu W; Liu S
    Immunol Invest; 2020 Apr; 49(3):307-316. PubMed ID: 31401902
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
    Meng X; Yang B; Suen WC
    Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Diagnostic Challenges and Complex Management of Consecutive Twin Pregnancies in a Family with CD40 Ligand Deficiency.
    Török O; Tóth B; Erdős M; Csorba G; Gyimesi E; Balogh I; Tóth Z; Maródi L
    Scand J Immunol; 2012 Feb; 75(2):227-30. PubMed ID: 21958324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked hyper-immunoglobulin M syndrome harboring a novel CD40-ligand gene mutation: a case report.
    Ramachandran R; Krishnan Y; Singh P; Kumar A; Mohanty A
    Immunogenetics; 2023 Apr; 75(2):191-194. PubMed ID: 36478253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Sequential Liver and Hematopoietic Stem Cell Transplantation in a Child With CD40 Ligand Deficiency and Cryptosporidium-Induced Liver Cirrhosis.
    Quarello P; Tandoi F; Carraro F; Vassallo E; Pinon M; Romagnoli R; David E; Dell Olio D; Salizzoni M; Fagioli F; Calvo PL
    Transplantation; 2018 May; 102(5):823-828. PubMed ID: 29377874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 ligand deficiency with grade III liver fibrosis, transplanted by a treosulphan-based conditioning regimen.
    Dogu F; Cipe FE; Reisli I; Erden E; Ikinciogullari A
    Exp Clin Transplant; 2011 Oct; 9(5):349-52. PubMed ID: 21967264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy.
    Atarod L; Aghamohammadi A; Moin M; Kanegane H; Rezaei N; Rezaei Kalantari K; Amirzagar AA; Futatani T; Miyawaki M
    Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):37-40. PubMed ID: 17303928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: report of four cases and review of the literature.
    Erdos M; Garami M; Rákóczi E; Zalatnai A; Steinbach D; Baumann U; Kropshofer G; Tóth B; Maródi L
    Clin Immunol; 2008 Dec; 129(3):455-61. PubMed ID: 18805740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study.
    Ferrua F; Galimberti S; Courteille V; Slatter MA; Booth C; Moshous D; Neven B; Blanche S; Cavazzana M; Laberko A; Shcherbina A; Balashov D; Soncini E; Porta F; Al-Mousa H; Al-Saud B; Al-Dhekri H; Arnaout R; Formankova R; Bertrand Y; Lange A; Smart J; Wolska-Kusnierz B; Aquino VM; Dvorak CC; Fasth A; Fouyssac F; Heilmann C; Hoenig M; Schuetz C; Kelečić J; Bredius RGM; Lankester AC; Lindemans CA; Suarez F; Sullivan KE; Albert MH; Kałwak K; Barlogis V; Bhatia M; Bordon V; Czogala W; Alonso L; Dogu F; Gozdzik J; Ikinciogullari A; Kriván G; Ljungman P; Meyts I; Mustillo P; Smith AR; Speckmann C; Sundin M; Keogh SJ; Shaw PJ; Boelens JJ; Schulz AS; Sedlacek P; Veys P; Mahlaoui N; Janda A; Davies EG; Fischer A; Cowan MJ; Gennery AR;
    J Allergy Clin Immunol; 2019 Jun; 143(6):2238-2253. PubMed ID: 30660643
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.